scholarly journals Video Assisted Thoracoscopic Treatment of Pleuropericardial Cysts

2001 ◽  
Vol 7 (2) ◽  
pp. 47-53 ◽  
Author(s):  
F. H. W. Hermens ◽  
F. J. Visser ◽  
A. Termeer ◽  
W. B. Barendregt ◽  
J. P. Janssen
Keyword(s):  
General Anaesthesia ◽  
Local Anaesthesia ◽  
Superior Vena Cava Syndrome ◽  
Superior Vena ◽  
Vena Cava ◽  
Vena Cava Syndrome ◽  
Talc Poudrage ◽  
Lost To Follow Up

Question of the Study In this study, safety and feasibility of thoracoscopic fenestration of pleuropericardial cysts under local and general anaesthesia is evaluated. Besides, a rare case of a pleural cyst, causing a superior vena cava syndrome, is described.Materials, Patients and Methods In a retrospective study, the results of thoracoscopic treatment of pleuropericardial cysts in three patients are presented. We performed videothoracoscopic fenestration of pleuropericardial cysts. One of these was performed under local anaesthesia. The two other cases were performed under general anaesthesia. After fenestration, talc poudrage of the inner lining of the cysts was performed in one case.Results Thoracoscopic fenestration appeared to be safe and effective. No recurrence was observed. One patient was lost to follow-up.Answer to the Question Thoracoscopic fenestration of pleuropericardial cysts is safe and effective. This procedure can be performed under local anaesthesia in selected cases. The role of talc poudrage of the cysts is unclear and needs further investigation.

scholarly journals Superior Vena Cava Syndrome following General Anaesthesia

1992 ◽  
Vol 20 (2) ◽  
pp. 229-232 ◽  
Author(s):  
R. H. Riley ◽  
L. A. Harris ◽  
N. J. Davis ◽  
J. M. Lagerberg
Keyword(s):  
General Anaesthesia ◽  
Superior Vena Cava ◽  
Superior Vena Cava Syndrome ◽  
Superior Vena ◽  
Vena Cava ◽  
Vena Cava Syndrome

scholarly journals Endovascular therapy of acute tumour-related obstruction of the superior vena cava using a self-expanding Nitinol stent

2013 ◽  
Vol 17 (4) ◽  
pp. 123-127
Author(s):  
Peter Kamusella ◽  
Christian Wissgott ◽  
Reimer Andresen
Keyword(s):  
Superior Vena Cava ◽  
Endovascular Therapy ◽  
Superior Vena Cava Syndrome ◽  
Tumour Progression ◽  
Superior Vena ◽  
Vena Cava ◽  
Bronchial Carcinoma ◽  
Nitinol Stent ◽  
Vena Cava Syndrome

Objective: To evaluate, in a retrospective study, the clinical efficacy and safety of the self-expanding Nitinol stent in the superior vena cava to alleviate upper venous congestion.Method: In 22 patients (15 men, 7 women), a tumour-related compression of the superior vena cava was diagnosed by spiral CT after intravenous application of contrast medium. Clinically, acute superior vena cava syndrome was found in all patients. Histologically, a bronchial carcinoma was present in 14/22, a lymphoma in 6/22, and mediastinal lymphnode metastases (1 breast carcinoma, 1 malignant melanoma) in 2/22. After a transfemoral approach, cavography was initially performed. The degree of stenosis was classified according to the Stanford classification. In accordance with the degree of stenosis, a self-expanding Nitinol stent was placed.Results: Endovascular stent implantation was conducted without complications in all patients. A marked improvement in acute symptoms was observed clinically within 24 hours in all patients. In the follow-up period of up to 2 years, there were no cases of stent migration. In 7/22 patients, the CT follow-ups revealed tumour progression (3/7 after 3 months, 2/7 after 6 months, and 2/7 after 12 months) with evidence of residual stenosis caused by tumour growth through the stent mesh. During the follow-up period, 15/22 patients died (mean survival 6.4 months).Conclusion: Self-expanding Nitinol stents provide endovascular therapy for superior vena cava syndrome, having a high radial expansive force and the facility to be placed precisely, and alleviating acute, life-threatening symptoms in the palliative situation.

scholarly journals EP-1436: The superior vena cava syndrome (SVCS): role of the radiotherapy

2016 ◽  
Vol 119 ◽  
pp. S667
Author(s):  
M.S. Mariaquila Santoro ◽  
M.L. Marianna Lacaria ◽  
M.A.M. Maria Angela Molinaro ◽  
L.R.F. Lucia Rachele Fabiano ◽  
A.D. Anna Destito ◽  
...  
Keyword(s):  
Superior Vena Cava ◽  
Superior Vena Cava Syndrome ◽  
Superior Vena ◽  
Vena Cava ◽  
Vena Cava Syndrome

Pacemaker-Induced Superior Vena Cava Syndrome: Clinical Evaluation of Long-Term Follow-Up

2006 ◽  
Vol 29 (12) ◽  
pp. 1346-1351 ◽  
Author(s):  
CHRISTOPH MELZER ◽  
ALEXANDER LEMBCKE ◽  
SABINE ZIEMER ◽  
STEPHAN EDDICKS ◽  
JOACHIM WITTE ◽  
...  
Keyword(s):  
Superior Vena Cava ◽  
Clinical Evaluation ◽  
Superior Vena Cava Syndrome ◽  
Superior Vena ◽  
Vena Cava ◽  
Long Term Follow Up ◽  
Vena Cava Syndrome

Superior vena cava syndrome associated with Behcet’s disease and 18 months’ follow up: a case report

2008 ◽  
Vol 28 (8) ◽  
pp. 807-809 ◽  
Author(s):  
Ilhan Sezer ◽  
M. Alkan Melikoglu ◽  
H. Fatih Çay ◽  
Hilal Kocabaş ◽  
Bülent Bütün
Keyword(s):  
Case Report ◽  
Superior Vena Cava ◽  
Behcet’S Disease ◽  
Superior Vena Cava Syndrome ◽  
Behçet's Disease ◽  
Superior Vena ◽  
Vena Cava ◽  
Behcet's Disease ◽  
Vena Cava Syndrome

scholarly journals Thoracic duct–azygos vein anastomosis in an infant with superior vena cava syndrome and recurrent chylothorax

2020 ◽  
Vol 31 (2) ◽  
pp. 280-281
Author(s):  
Geoffroy de Beco ◽  
Joëlle Van Winghem ◽  
Benoît Lengelé ◽  
Alain J Poncelet
Keyword(s):  
Pleural Effusion ◽  
Surgical Technique ◽  
Enteral Nutrition ◽  
Superior Vena Cava Syndrome ◽  
Superior Vena ◽  
Vena Cava ◽  
Azygos Vein ◽  
Venous Anastomosis ◽  
Vena Cava Syndrome

Abstract In this study, we describe an intrathoracic microsurgical lymphatico-venous anastomosis as an alternative surgical technique for the treatment of refractory chylothorax in an infant. This procedure allowed us to restore enteral nutrition within days of surgery. At 3-year follow-up, there was no recurrence of pleural effusion.

scholarly journals Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Haitao Liu ◽  
Yahua Li ◽  
Yang Wang ◽  
Lei Yan ◽  
Pengli Zhou ◽  
...  
Keyword(s):  
Superior Vena Cava ◽  
Stent Placement ◽  
Superior Vena Cava Syndrome ◽  
Clinical Symptoms ◽  
Malignant Tumors ◽  
Superior Vena ◽  
Vena Cava ◽  
Tumor Type ◽  
Vena Cava Syndrome

Abstract Objectives To evaluate the efficacy of percutaneous stent placement in the treatment of superior vena cava syndrome caused by malignant tumors. Methods We retrospectively analyzed the clinical data of 32 patients with superior vena cava syndrome who underwent percutaneous endovascular stent treatment in our department from 2015 to 2019 due to malignant tumors and summarized the patient’s sex, age, tumor type, endovascular treatment plan, complications and postoperative follow-up. Results All patients successfully underwent percutaneous intraluminal stent placement with digital subtraction angiography (DSA). Thirty-seven endovascular stents were implanted in 32 patients, including 21 Eluminexx stents, 12 Wallstent stents and 4 covered stents. The technical success rate was 100%, and there were no serious surgery-related complications. The remission rate of clinical symptoms was 53.1% (17/32) at 24 h and 84.4% (27/32) at 48 h. After 48 h, the symptoms of the remaining patients were slowly relieved, and the symptom relief rate was 100% at 7 days. The follow-up period was 1.5–24 months, with an average follow-up period of 6.5 months. During the follow-up, 3 patients had restenosis and 1 patient had secondary thrombosis in the stent. Their symptoms were relieved after the second treatment. Conclusion For superior vena cava syndrome caused by malignant tumors, percutaneous endoluminal stent therapy can quickly and effectively relieve the clinical symptoms of patients, and the incidence of complications is low.

Sign in / Sign up

Export Citation Format

Share Document